Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 15 | $44,842,493 |
| Sells | 2 | $17,448,750 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 06 Jun 2024 17:01 | OLMA | Olema Pharmaceuticals Inc | GRAHAM G. WALMSLEY | Director | 04 Jun 2024 | Sale | 475,000 | 14.85 | 7,053,750 | I |
| 06 Jun 2024 17:01 | OLMA | Olema Pharmaceuticals Inc | GRAHAM G. WALMSLEY | Director | 04 Jun 2024 | Sale | 700,000 | 14.85 | 10,395,000 | I |
| 18 Dec 2023 18:30 | OLMA | Olema Pharmaceuticals Inc | GRAHAM G. WALMSLEY | Director | 05 Dec 2023 | Purchase | 50,000 | 13.085 | 654,250 | I |
| 18 Dec 2023 18:30 | OLMA | Olema Pharmaceuticals Inc | GRAHAM G. WALMSLEY | Director | 05 Dec 2023 | Purchase | 50,000 | 14.9496 | 747,480 | I |
| 18 Dec 2023 18:30 | OLMA | Olema Pharmaceuticals Inc | GRAHAM G. WALMSLEY | Director | 12 Sep 2023 | Purchase | 508,130 | 9.84 | 4,999,999 | I |
| 18 Dec 2023 18:30 | OLMA | Olema Pharmaceuticals Inc | GRAHAM G. WALMSLEY | Director | 05 Dec 2023 | Purchase | 31,870 | 14.7333 | 469,550 | I |
| 11 Dec 2023 21:06 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 08 Dec 2023 | Purchase | 50,000 | 19.854 | 992,700 | I |
| 11 Dec 2023 21:06 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 08 Dec 2023 | Purchase | 50,000 | 19.8048 | 990,240 | I |
| 05 Dec 2023 08:37 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 01 Dec 2023 | Purchase | 50,000 | 16.9946 | 849,730 | I |
| 05 Dec 2023 08:37 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 30 Nov 2023 | Purchase | 50,000 | 16.8967 | 844,835 | I |
| 10 Aug 2023 16:46 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 08 Aug 2023 | Purchase | 25,000 | 42.059 | 1,051,475 | I |
| 01 Aug 2023 19:52 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 01 Aug 2023 | Purchase | 25,000 | 43.261 | 1,081,525 | I |
| 01 Aug 2023 19:52 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 28 Jul 2023 | Purchase | 30,000 | 42.6903 | 1,280,709 | I |
| 15 Jun 2023 21:26 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 19 May 2023 | Purchase A | 120,000 | 42 | 5,040,000 | I |
| 15 Jun 2023 21:26 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 19 Sep 2022 | Purchase A | 400,000 | 26 | 10,400,000 | I |
| 23 May 2023 21:55 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 19 May 2023 | Purchase | 120,000 | 42 | 5,040,000 | I |
| 23 May 2023 21:55 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 19 Sep 2023 | Purchase | 400,000 | 26 | 10,400,000 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)